走向“可能”:概率、潜在竞争和克莱顿法案

D. Bloomfield
{"title":"走向“可能”:概率、潜在竞争和克莱顿法案","authors":"D. Bloomfield","doi":"10.2139/ssrn.3589820","DOIUrl":null,"url":null,"abstract":"Current merger review law is critically flawed. Courts in Clayton Act Section 7 cases consider the likelihood that a merger will harm competition as a threshold question before considering the size of harm that could ensue. Under current law, to block a merger a judge must find that the deal is likely to substantially harm competition. But this likelihood threshold is neither sound policy nor required by the law. The statute—barring mergers whose effects “may be substantially to lessen competition”—instructs courts to evaluate the likelihood and magnitude of harm that a merger could cause together, rather than separately. Considering likelihood without simultaneously weighing magnitude is to miss half the story. Courts should instead bar mergers whose expected effect, multiplying likelihood of harm by magnitude of harm, is to significantly harm competition. <br><br>Applying an expected-effects test will also fix our broken potential competition doctrine. Because it is often impossible to show that a merger between a dominant firm and its potential rival is more likely than not to significantly harm competition, the Clayton Act is a dead letter as applied to such mergers. Discarding the likelihood threshold reveals how harmful many such mergers are on average, and will address the problem of incumbents buying their startup competitors.<br><br>To implement this test, I propose a new structural presumption for mergers between incumbents and potential rivals. The test stays within current statutory language and would help to block mergers that pose the greatest threat to future competition. <br>","PeriodicalId":13563,"journal":{"name":"Insurance & Financing in Health Economics eJournal","volume":"57 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Getting to \\\"May Be\\\": Probability, Potential Competition, and the Clayton Act\",\"authors\":\"D. Bloomfield\",\"doi\":\"10.2139/ssrn.3589820\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Current merger review law is critically flawed. Courts in Clayton Act Section 7 cases consider the likelihood that a merger will harm competition as a threshold question before considering the size of harm that could ensue. Under current law, to block a merger a judge must find that the deal is likely to substantially harm competition. But this likelihood threshold is neither sound policy nor required by the law. The statute—barring mergers whose effects “may be substantially to lessen competition”—instructs courts to evaluate the likelihood and magnitude of harm that a merger could cause together, rather than separately. Considering likelihood without simultaneously weighing magnitude is to miss half the story. Courts should instead bar mergers whose expected effect, multiplying likelihood of harm by magnitude of harm, is to significantly harm competition. <br><br>Applying an expected-effects test will also fix our broken potential competition doctrine. Because it is often impossible to show that a merger between a dominant firm and its potential rival is more likely than not to significantly harm competition, the Clayton Act is a dead letter as applied to such mergers. Discarding the likelihood threshold reveals how harmful many such mergers are on average, and will address the problem of incumbents buying their startup competitors.<br><br>To implement this test, I propose a new structural presumption for mergers between incumbents and potential rivals. The test stays within current statutory language and would help to block mergers that pose the greatest threat to future competition. <br>\",\"PeriodicalId\":13563,\"journal\":{\"name\":\"Insurance & Financing in Health Economics eJournal\",\"volume\":\"57 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-06-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Insurance & Financing in Health Economics eJournal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2139/ssrn.3589820\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Insurance & Financing in Health Economics eJournal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2139/ssrn.3589820","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

目前的合并审查法存在严重缺陷。在克莱顿法第7条案件中,法院在考虑可能产生的损害的大小之前,会将合并损害竞争的可能性作为一个门槛问题来考虑。根据现行法律,要阻止合并,法官必须发现该交易可能会严重损害竞争。但这种可能性门槛既不是合理的政策,也不是法律所要求的。该法规禁止合并,其影响“可能实质上减少竞争”,指示法院评估合并可能造成的损害的可能性和程度,而不是单独的。只考虑可能性而不同时衡量量级,只会错过一半的故事。相反,法院应该禁止那些预期影响(将损害的可能性乘以损害的程度)会严重损害竞争的合并。应用预期效应检验也将修复我们支离破碎的潜在竞争原则。因为通常不可能证明一家占主导地位的公司与其潜在竞争对手之间的合并更有可能严重损害竞争,所以《克莱顿法》适用于此类合并是一纸空文。抛弃可能性阈值揭示了许多此类合并的平均危害,并将解决现有企业收购初创竞争对手的问题。为了实施这一检验,我提出了一种新的结构性假设,适用于现有企业与潜在竞争对手之间的合并。该测试符合当前的法定语言,将有助于阻止对未来竞争构成最大威胁的合并。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Getting to "May Be": Probability, Potential Competition, and the Clayton Act
Current merger review law is critically flawed. Courts in Clayton Act Section 7 cases consider the likelihood that a merger will harm competition as a threshold question before considering the size of harm that could ensue. Under current law, to block a merger a judge must find that the deal is likely to substantially harm competition. But this likelihood threshold is neither sound policy nor required by the law. The statute—barring mergers whose effects “may be substantially to lessen competition”—instructs courts to evaluate the likelihood and magnitude of harm that a merger could cause together, rather than separately. Considering likelihood without simultaneously weighing magnitude is to miss half the story. Courts should instead bar mergers whose expected effect, multiplying likelihood of harm by magnitude of harm, is to significantly harm competition.

Applying an expected-effects test will also fix our broken potential competition doctrine. Because it is often impossible to show that a merger between a dominant firm and its potential rival is more likely than not to significantly harm competition, the Clayton Act is a dead letter as applied to such mergers. Discarding the likelihood threshold reveals how harmful many such mergers are on average, and will address the problem of incumbents buying their startup competitors.

To implement this test, I propose a new structural presumption for mergers between incumbents and potential rivals. The test stays within current statutory language and would help to block mergers that pose the greatest threat to future competition.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信